Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy

Background and Objectives The impact of perioperative blood transfusion (PBT) on outcomes for pancreatic ductal adenocarcinoma (PDAC) patients given multimodality therapy (MMT) remains undefined. We sought to evaluate the association of PBT with survival after PDAC resection. Methods Pancreatectomy patients (July 2011–December 2017) who received MMT were abstracted from a prospective database. Overall survival (OS) was compared by PBT within 30...